MSA - MULTIPLE SYSTEM ATROPHY
Clinical trials for MSA - MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MSA - MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MSA - MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for MSA patients: drug targets debilitating blood pressure drops
Disease control OngoingThis study tests a drug called ampreloxetine for people with multiple system atrophy (MSA) who experience severe dizziness or fainting due to low blood pressure when standing. About 102 adults aged 30 and older with MSA will receive the drug for 20 weeks, then some will switch to…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Disease control
Last updated May 01, 2026 20:27 UTC
-
Nurse-Led video care may ease daily life for rare parkinsonism patients
Symptom relief OngoingThis study tests whether a home-based telenursing program, led by a specialist nurse, can improve quality of life and reduce complications like falls for people with atypical parkinsonism (MSA or PSP). About 164 participants will receive proactive and reactive video monitoring an…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC